India Glycols Limited - chemicals and materials in Udham Singh Nagar, Uttarakhand, India. FY 2026 financials and compliance.
CIN L24111UR1983PLC009097 Incorporated 19 November 1983 ROC Uttarakhand HQ Udham Singh Nagar, Uttarakhand, India
Active Listed - NSE: INDIAGLYCO · BSE: 500201 Public Limited Company chemicals and materials
Data last updated
Revenue · FY 2026
₹9,826.63 Cr
▲ 8.71% YoY
EBITDA · FY 2026
₹654.18 Cr
▲ 24.49% YoY
Net profit · FY 2026
₹292.76 Cr
▲ 26.78% YoY
Authorised capital
₹45 Cr
Registered with MCA
Paid-up capital
₹33.51 Cr
Issued & subscribed
Open charges
₹3,185.68 Cr
Satisfied ₹12,932 Cr
Company age
43 yrs
Est. 1983
Employees · EPFO
1,347
Latest available

About India Glycols Limited

Data last updated: 02 July 2026

India Glycols Limited is a public limited company based in Udham Singh Nagar, Uttarakhand, India. It specialises in specialty chemicals, a part of the broader chemicals and materials sector. Incorporated on 19 November 1983, the company has been in operation for over 43 years.

Registered with ROC Uttarakhand under CIN L24111UR1983PLC009097. Listed on BSE: 500201 and NSE: INDIAGLYCO.

Capital: an authorised share capital of ₹45 Cr and a paid-up capital of ₹33.51 Cr. It is led by directors including Uma Shankar Bhartia and Pragya Bhartia Barwale.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: A – 1 Industrial Area Bazpur Road Kashipur, Udham Singh Nagar, Uttarakhand, India – 244713.

As per the financials filed for FY 2025, the company reported a revenue of ₹9,053.5 Cr, a growth of 14% compared to the previous year.

The company has a workforce of approximately 1,347 employees as per the latest available data. Its group structure includes 3 subsidiaries and 1 joint venture.

The company is associated with 3 brands - Ennature Biopharma, Principle Circle, India Glycols. As per MCA filings, the company has open charges of ₹3,185.68 Cr and satisfied charges of ₹12,932 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website indiaglycols.com.

Company Details of India Glycols Limited
CIN L24111UR1983PLC009097
Registration Number 009097
Incorporation Date 19 November 1983
ROC Uttarakhand
Listing Status Listed (BSE: 500201, NSE: INDIAGLYCO)
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Social Media
  • Registered Address
    A – 1 Industrial Area Bazpur Road Kashipur, Udham Singh Nagar, Uttarakhand, India – 244713
  • Industry
    Chemicals and Materials, Specialty Chemicals, Industrial & Specialty Gases
Company report
India Glycols Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full India Glycols Limited report

Financials, compliance, directors, charges, ownership and filings for India Glycols Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of India Glycols Limited

India Glycols Limited has one previous CIN (Corporate Identification Number): L24111UP1983PLC009097. The current CIN is L24111UR1983PLC009097, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24111UR1983PLC009097 Current
L24111UP1983PLC009097 Previous

Associated Brands with India Glycols Limited

India Glycols Limited operates multiple associated brands including Ennature Biopharma, Principle Circle, and India Glycols. These brands represent India Glycols Limited's diversified market presence and brand portfolio.

Brand Description Website
Manufactures and supplies pure nicotine, pharmaceutical actives, and nutraceutical ingredients globally. ennaturebiopharma.com
Offers management consulting and innovative products in education and entertainment sectors. principlecircle.com
Bulk, specialty, and performance chemicals are supplied to various industries. indiaglycols.com

Competitors & Alternatives of India Glycols Limited

Brands and companies operating in the same space as India Glycols Limited include TeamLease, Laurus Labs, Cyient and 7 more.

Competitor Description Location Founded
TeamLease TeamLease Staffing and recruiting services connect employers with job candidates. Bengaluru, India, India 2000
Laurus Labs Laurus Labs Pharmaceutical and biotechnology company Hyderabad, India, India 2005
Cyient Cyient Provider of digital engineering and technology services Hyderabad, India, India 1991
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured. Indore, India, India 2002
Huron Consulting Group Huron Consulting Group Advisory, consulting, technology, and analytics solutions are provided across industries. Amman, Jordan, Jordan 2002
Manus Bio Manus Bio Phytochemicals are developed using microbial fermentation processes. Cambridge, United States, United States 2011
LanzaTech LanzaTech Waste carbon is treated via a bio-processing platform. Skokie, United States, United States 2005
Cognizant Cognizant Provider of software development, cloud & data management, and IT consulting services United States 1994
Beijing Biostar Technologies Beijing Biostar Technologies APIs, intermediates, and biochemical reagents are developed and manufactured. Beijing, China, China 2002
LS Digital LS Digital Business consulting, activation, and transformation services are provided. Navi Mumbai, India, India 2006

Business Activity of India Glycols Limited

India Glycols Limited is engaged in principal business activities including manufacturing and trade, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, wholesale trading. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********
G Trade G1 Wholesale Trading *********

Auditor Details of India Glycols Limited

India Glycols Limited is audited by M/s K N Gutgutia & Co. (ICAI peer reviewed, certificate valid till 2027-11-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
M/s K N Gutgutia & Co. (ICAI peer reviewed, certificate valid till 2027-11-30) FY 2026 Declaration of unmodified opinion

Board of Directors of India Glycols Limited

India Glycols Limited is currently managed by 11 directors, with 23 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Uma Shankar Bhartia Managing Director 29 Nov 1996 29 Years 7 Months Current
Pragya Bhartia Barwale Whole-Time Director 24 Jun 2020 6 Years 0 Months Current
Shukla Wassan Director 01 Apr 2020 6 Years 3 Months Current
Jayshree Bhartia Director 28 May 1999 27 Years 1 Months Current
Samrat Banerjee Director 01 Oct 2024 1 Years 9 Months Current
Sushil Dutt Salwan Director 01 Oct 2024 1 Years 9 Months Current
Showing 6 of 11 current directors. View all directors

Financials of India Glycols Limited FY 2026 filings available

India Glycols Limited reported revenue of ₹9,826.63 Cr (up 8.71% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹9,826.63 Cr ▲ 8.71%
Profit · FY 2026
₹292.76 Cr ▲ 26.78%
EBITDA · FY 2026
₹654.18 Cr ▲ 24.49%
Revenue₹ Cr · Consolidated05,00010,000FY 2020: ₹5,973 Cr5,973FY 2020FY 2021: ₹5,427 Cr · -9.1% YoY5,427-9.1%FY 2021FY 2022: ₹6,601 Cr · +21.6% YoY6,601+21.6%FY 2022FY 2023: ₹6,642 Cr · +0.6% YoY6,642+0.6%FY 2023FY 2024: ₹7,922 Cr · +19.3% YoY7,922+19.3%FY 2024FY 2025: ₹9,039 Cr · +14.1% YoY9,039+14.1%FY 2025FY 2026: ₹9,827 Cr · +8.7% YoY9,827+8.7%FY 2026
Net Profit₹ Cr · Consolidated0200400FY 2020: ₹115 Cr115FY 2020FY 2021: ₹132 Cr · +14.8% YoY132+14.8%FY 2021FY 2022: ₹340 Cr · +158.2% YoY340+158.2%FY 2022FY 2023: ₹141 Cr · -58.5% YoY141-58.5%FY 2023FY 2024: ₹173 Cr · +22.7% YoY173+22.7%FY 2024FY 2025: ₹231 Cr · +33.5% YoY231+33.5%FY 2025FY 2026: ₹293 Cr · +26.8% YoY293+26.8%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year01,0002,0003,000Q1'25: ₹2,283 Cr · +20.5% YoY2,283+20.5%Q1'25Q2'25: ₹2,144 Cr · +14.6% YoY2,144+14.6%Q2'25Q3'25: ₹2,424 Cr · +14.4% YoY2,424+14.4%Q3'25Q4'25: ₹2,189 Cr · +7.3% YoY2,189+7.3%Q4'25Q1'26: ₹2,503 Cr · +9.7% YoY2,503+9.7%Q1'26Q2'26: ₹2,412 Cr · +12.5% YoY2,412+12.5%Q2'26Q3'26: ₹2,551 Cr · +5.2% YoY2,551+5.2%Q3'26Q4'26: ₹2,360 Cr · +7.8% YoY2,360+7.8%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹9,826.63 Cr ₹9,038.95 Cr ₹7,921.54 Cr ₹6,641.64 Cr ₹6,601.41 Cr ₹5,427.47 Cr ₹5,972.65 Cr
Other Income ₹4.93 Cr ₹14.55 Cr ₹25.73 Cr ₹23.89 Cr ₹21.54 Cr ₹15.26 Cr ₹8.77 Cr
Total Income ₹9,831.56 Cr ₹9,053.5 Cr ₹7,947.27 Cr ₹6,665.53 Cr ₹6,622.95 Cr ₹5,442.73 Cr ₹5,981.42 Cr
Cost of Materials Consumed ₹2,412.43 Cr ₹2,345.81 Cr ₹1,818.92 Cr ₹1,444.75 Cr ₹1,666.94 Cr ₹1,185.6 Cr ₹1,685.7 Cr
Purchases of Stock-in-Trade ₹187.22 Cr ₹113.59 Cr ₹321.8 Cr ₹160.12 Cr ₹351.37 Cr ₹328.27 Cr ₹630.89 Cr
Changes in Inventories ₹62.35 Cr -₹51.55 Cr ₹8.11 Cr -₹22.56 Cr -₹96.89 Cr -₹14.7 Cr ₹11.62 Cr
Employee Benefit Expense ₹132.61 Cr ₹122.69 Cr ₹103.37 Cr ₹88.8 Cr ₹89.16 Cr ₹83.33 Cr ₹114.38 Cr
Finance Costs ₹167.18 Cr ₹164.37 Cr ₹120.67 Cr ₹99.96 Cr ₹69.66 Cr ₹83.38 Cr ₹143.41 Cr
Depreciation & Amortisation ₹155.38 Cr ₹115.2 Cr ₹100.77 Cr ₹93.96 Cr ₹80.29 Cr ₹80.12 Cr ₹82.97 Cr
Other Expenses ₹6,382.77 Cr ₹5,997.47 Cr ₹5,266.98 Cr ₹4,675 Cr ₹4,335.63 Cr ₹3,576.97 Cr ₹3,138.13 Cr
Total Expenses ₹9,499.94 Cr ₹8,807.58 Cr ₹7,740.62 Cr ₹6,540.03 Cr ₹6,496.16 Cr ₹5,322.97 Cr ₹5,807.1 Cr
Profit Before Exceptional Items & Tax ₹331.62 Cr ₹245.92 Cr ₹206.65 Cr ₹125.5 Cr ₹126.79 Cr ₹119.76 Cr ₹174.32 Cr
Exceptional Items -₹83 Lakh ₹0 ₹0 ₹28.13 Cr ₹221.34 Cr ₹0 ₹0
Profit Before Tax ₹330.79 Cr ₹245.92 Cr ₹206.65 Cr ₹153.63 Cr ₹348.13 Cr ₹119.76 Cr ₹174.32 Cr
Total Tax Expense ₹84.45 Cr ₹61.4 Cr ₹50.32 Cr ₹23.96 Cr ₹39.43 Cr ₹11.28 Cr ₹59.25 Cr
Net Profit ₹292.76 Cr ₹230.92 Cr ₹172.99 Cr ₹141.04 Cr ₹339.85 Cr ₹131.61 Cr ₹114.66 Cr
  attributable to Owners ₹292.76 Cr ₹230.92 Cr ₹172.99 Cr ₹125.08 Cr ₹339.85 Cr ₹131.61 Cr ₹114.66 Cr
  attributable to NCI ₹0 ₹0 ₹0 ₹15.96 Cr ₹0 ₹0 ₹0
Other Comprehensive Income -₹1.62 Cr -₹1.3 Cr -₹19 Lakh ₹40 Lakh -₹47 Lakh ₹3.05 Cr -₹1.36 Cr
Total Comprehensive Income ₹291.14 Cr ₹229.62 Cr ₹172.8 Cr ₹141.44 Cr ₹339.38 Cr ₹134.66 Cr ₹113.3 Cr
EBITDA (computed) ₹654.18 Cr ₹525.49 Cr ₹428.09 Cr ₹319.42 Cr ₹276.74 Cr ₹283.26 Cr ₹400.7 Cr
Basic EPS ₹45.95 ₹74.58 ₹55.87 ₹45.55 ₹106.45 ₹35.27 ₹37.03
Diluted EPS ₹45.95 ₹74.58 ₹55.87 ₹45.55 ₹106.45 ₹35.27 ₹37.03
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹6,522.95 Cr ₹6,176.1 Cr ₹5,616.8 Cr ₹4,858.33 Cr
Non-current Assets ₹5,025.14 Cr ₹4,359.88 Cr ₹3,672.1 Cr ₹3,212.09 Cr
Current Assets ₹1,497.81 Cr ₹1,816.22 Cr ₹1,944.7 Cr ₹1,646.24 Cr
Property, Plant & Equipment ₹4,551.29 Cr ₹3,825.95 Cr ₹3,196.77 Cr ₹2,707.37 Cr
Inventories ₹890.61 Cr ₹1,170.88 Cr ₹1,106.29 Cr ₹753.83 Cr
Trade Receivables ₹351.4 Cr ₹364.97 Cr ₹384.1 Cr ₹430.34 Cr
Cash & Equivalents ₹31.87 Cr ₹6.84 Cr ₹26.96 Cr ₹1.97 Cr
Equity (Net Worth) ₹2,932.78 Cr ₹2,255.88 Cr ₹2,051.02 Cr ₹1,901.42 Cr
Equity Share Capital ₹33.51 Cr ₹30.96 Cr ₹30.96 Cr ₹30.96 Cr
Borrowings (Non-current) ₹919.13 Cr ₹1,040.09 Cr ₹725.08 Cr ₹550.77 Cr
Borrowings (Current) ₹659.34 Cr ₹764.18 Cr ₹596.03 Cr ₹543.3 Cr
Total Debt (computed) ₹1,578.47 Cr ₹1,804.27 Cr ₹1,321.11 Cr ₹1,094.07 Cr
Current Liabilities ₹2,014.11 Cr ₹2,321.04 Cr ₹2,374.73 Cr ₹1,864.93 Cr
Total Liabilities ₹3,590.17 Cr ₹3,920.22 Cr ₹3,565.78 Cr ₹2,956.91 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹769.17 Cr ₹362.11 Cr ₹438.51 Cr ₹325.71 Cr ₹91.42 Cr
Investing Cash Flow -₹766.68 Cr -₹735.99 Cr -₹503.45 Cr -₹330.28 Cr ₹93.13 Cr
Financing Cash Flow ₹22.54 Cr ₹353.76 Cr ₹89.93 Cr -₹51 Lakh -₹180.89 Cr
Capital Expenditure ₹823.48 Cr ₹760.47 Cr ₹552.93 Cr ₹438.77 Cr ₹379.92 Cr
Free Cash Flow (computed) -₹54.31 Cr -₹398.36 Cr -₹114.42 Cr -₹113.06 Cr -₹288.5 Cr
Dividends Paid ₹75.31 Cr ₹24.59 Cr ₹22.97 Cr ₹23.04 Cr ₹18.39 Cr
Net Change in Cash ₹25.03 Cr -₹20.12 Cr ₹24.99 Cr -₹5.08 Cr ₹3.66 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹2,360.01 Cr ₹2,551.1 Cr ₹2,412.4 Cr ₹2,503.12 Cr ₹2,188.65 Cr ₹2,424.01 Cr ₹2,143.71 Cr ₹2,282.58 Cr ₹2,039.08 Cr ₹2,118.94 Cr ₹1,869.88 Cr ₹1,893.64 Cr
Other Income ₹62 Lakh ₹74 Lakh ₹2.17 Cr ₹1.4 Cr ₹1.59 Cr ₹5.82 Cr ₹4.34 Cr ₹2.8 Cr ₹4.65 Cr ₹4.55 Cr ₹10.73 Cr ₹5.8 Cr
Total Income ₹2,360.63 Cr ₹2,551.84 Cr ₹2,414.57 Cr ₹2,504.52 Cr ₹2,190.24 Cr ₹2,429.83 Cr ₹2,148.05 Cr ₹2,285.38 Cr ₹2,043.73 Cr ₹2,123.49 Cr ₹1,880.61 Cr ₹1,899.44 Cr
Cost of Materials Consumed ₹484.66 Cr ₹597.82 Cr ₹660.85 Cr ₹669.1 Cr ₹488.26 Cr ₹642.29 Cr ₹584.28 Cr ₹630.98 Cr ₹501.46 Cr ₹515.96 Cr ₹407.33 Cr ₹394.17 Cr
Purchases of Stock-in-Trade ₹38.79 Cr ₹40.84 Cr ₹63.25 Cr ₹44.34 Cr ₹32.27 Cr ₹25.39 Cr ₹34.48 Cr ₹21.45 Cr ₹115.69 Cr ₹114.16 Cr ₹88.06 Cr ₹3.89 Cr
Changes in Inventories ₹83.51 Cr ₹53.06 Cr -₹38.25 Cr -₹35.97 Cr ₹13.36 Cr -₹45.67 Cr ₹6 Cr -₹25.24 Cr ₹18.61 Cr -₹12.55 Cr ₹1.87 Cr ₹18 Lakh
Employee Benefit Expense ₹34.21 Cr ₹35.23 Cr ₹32.11 Cr ₹31.06 Cr ₹30.56 Cr ₹31.2 Cr ₹30.28 Cr ₹30.65 Cr ₹29.94 Cr ₹27.44 Cr ₹23.18 Cr ₹22.81 Cr
Finance Costs ₹26.41 Cr ₹46.81 Cr ₹49.28 Cr ₹44.68 Cr ₹44.53 Cr ₹44.07 Cr ₹39.91 Cr ₹35.86 Cr ₹32.63 Cr ₹31.41 Cr ₹29.05 Cr ₹27.58 Cr
Depreciation & Amortisation ₹41.23 Cr ₹41.22 Cr ₹38.48 Cr ₹34.45 Cr ₹32.59 Cr ₹27.47 Cr ₹27.57 Cr ₹27.57 Cr ₹26.04 Cr ₹26.24 Cr ₹27.96 Cr ₹20.53 Cr
Other Expenses ₹1,552.34 Cr ₹1,648.68 Cr ₹1,536.8 Cr ₹1,644.95 Cr ₹1,478.26 Cr ₹1,647.14 Cr ₹1,372.89 Cr ₹1,499.18 Cr ₹1,268.8 Cr ₹1,371.67 Cr ₹1,253.93 Cr ₹1,372.58 Cr
Total Expenses ₹2,261.15 Cr ₹2,463.66 Cr ₹2,342.52 Cr ₹2,432.61 Cr ₹2,119.83 Cr ₹2,371.89 Cr ₹2,095.41 Cr ₹2,220.45 Cr ₹1,993.17 Cr ₹2,074.33 Cr ₹1,831.38 Cr ₹1,841.74 Cr
Profit Before Exceptional Items & Tax ₹99.48 Cr ₹88.18 Cr ₹72.05 Cr ₹71.91 Cr ₹70.41 Cr ₹57.94 Cr ₹52.64 Cr ₹64.93 Cr ₹50.56 Cr ₹49.16 Cr ₹49.23 Cr ₹57.7 Cr
Exceptional Items ₹0 -₹83 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹99.48 Cr ₹87.35 Cr ₹72.05 Cr ₹71.91 Cr ₹70.41 Cr ₹57.94 Cr ₹52.64 Cr ₹64.93 Cr ₹50.56 Cr ₹49.16 Cr ₹49.23 Cr ₹57.7 Cr
Total Tax Expense ₹25.58 Cr ₹23.04 Cr ₹18.55 Cr ₹17.28 Cr ₹17.77 Cr ₹14.61 Cr ₹13.75 Cr ₹15.27 Cr ₹13.39 Cr ₹12.26 Cr ₹12.09 Cr ₹12.58 Cr
Net Profit ₹86.88 Cr ₹67.57 Cr ₹65.06 Cr ₹73.25 Cr ₹64.02 Cr ₹56.81 Cr ₹49.71 Cr ₹60.38 Cr ₹42.21 Cr ₹41.63 Cr ₹38.01 Cr ₹51.14 Cr
  attributable to Owners ₹86.88 Cr - ₹65.06 Cr ₹73.25 Cr ₹64.02 Cr - ₹49.71 Cr ₹60.38 Cr ₹42.21 Cr ₹41.63 Cr ₹38.01 Cr ₹51.14 Cr
  attributable to NCI ₹0 - - ₹0 ₹0 - - ₹0 ₹0 ₹0 ₹0 ₹0
Other Comprehensive Income -₹80 Lakh -₹25 Lakh -₹14 Lakh -₹43 Lakh -₹76 Lakh -₹42 Lakh -₹7 Lakh -₹5 Lakh -₹14 Lakh ₹51 Lakh -₹38 Lakh -₹18 Lakh
Total Comprehensive Income ₹86.08 Cr ₹67.32 Cr ₹64.92 Cr ₹72.82 Cr ₹63.26 Cr ₹56.39 Cr ₹49.64 Cr ₹60.33 Cr ₹42.07 Cr ₹42.14 Cr ₹37.63 Cr ₹50.96 Cr
EBITDA (computed) ₹167.12 Cr ₹176.21 Cr ₹159.81 Cr ₹151.04 Cr ₹147.53 Cr ₹129.48 Cr ₹120.12 Cr ₹128.36 Cr ₹109.23 Cr ₹106.81 Cr ₹106.24 Cr ₹105.81 Cr
Basic EPS ₹13.64 ₹10.79 ₹10.51 ₹23.66 ₹20.68 ₹18.35 ₹16.06 ₹19.50 ₹13.63 ₹13.45 ₹12.27 ₹16.52
Diluted EPS ₹13.64 ₹10.79 ₹10.51 ₹23.66 ₹20.68 ₹18.35 ₹16.06 ₹19.50 ₹13.63 ₹13.45 ₹12.27 ₹16.52
Latest 12 quarters shown of 25 on record.
Segment · Q4 FY26 (latest quarter) Revenue Result (PBIT) Assets Liabilities
Bio-based Specialities and Performance Chemicals ₹301.16 Cr ₹36.76 Cr ₹3,600.59 Cr ₹737.97 Cr
Potable Spirits ₹1,690.09 Cr ₹67.78 Cr ₹596.6 Cr ₹326.53 Cr
Ennature Biopharma ₹63.49 Cr ₹3.01 Cr ₹426.42 Cr ₹92.49 Cr
Bio-Fuel ₹305.27 Cr ₹30.21 Cr ₹1,429.96 Cr ₹92.27 Cr
Segment · FY 2026 (annual) Revenue Result (PBIT) Assets Liabilities
Bio-based Specialities and Performance Chemicals ₹1,202.5 Cr ₹140.95 Cr - -
Potable Spirits ₹6,946.43 Cr ₹284.93 Cr - -
Ennature Biopharma ₹207.77 Cr ₹7.23 Cr - -
Bio-Fuel ₹1,469.93 Cr ₹115.23 Cr - -
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹9,826.2 Cr ₹9,037.82 Cr ₹7,918.77 Cr ₹6,640.86 Cr ₹6,596.33 Cr ₹5,390 Cr ₹5,951.17 Cr
Other Income ₹43.51 Cr ₹14.55 Cr ₹25.73 Cr ₹27.59 Cr ₹26.53 Cr ₹12.08 Cr ₹12.18 Cr
Total Income ₹9,869.71 Cr ₹9,052.37 Cr ₹7,944.5 Cr ₹6,668.45 Cr ₹6,622.86 Cr ₹5,402.08 Cr ₹5,963.35 Cr
Cost of Materials Consumed ₹2,412.43 Cr ₹2,345.81 Cr ₹1,818.92 Cr ₹1,444.75 Cr ₹1,666.94 Cr ₹1,185.6 Cr ₹1,685.7 Cr
Purchases of Stock-in-Trade ₹188.46 Cr ₹111.8 Cr ₹319.68 Cr ₹159.49 Cr ₹350.36 Cr ₹300.9 Cr ₹610.87 Cr
Changes in Inventories ₹60.92 Cr -₹50.46 Cr ₹7.66 Cr -₹22.13 Cr -₹96.89 Cr -₹14.4 Cr ₹11.36 Cr
Employee Benefit Expense ₹130.69 Cr ₹120.89 Cr ₹101.62 Cr ₹87.13 Cr ₹87.59 Cr ₹81.69 Cr ₹112.48 Cr
Finance Costs ₹167.18 Cr ₹164.37 Cr ₹120.67 Cr ₹95.19 Cr ₹62.17 Cr ₹73.45 Cr ₹136.76 Cr
Depreciation & Amortisation ₹155.38 Cr ₹115.19 Cr ₹100.76 Cr ₹89.65 Cr ₹75.98 Cr ₹75.81 Cr ₹78.64 Cr
Other Expenses ₹6,387.12 Cr ₹6,002.99 Cr ₹5,273.14 Cr ₹4,674.1 Cr ₹4,335.96 Cr ₹3,578.71 Cr ₹3,140.03 Cr
Total Expenses ₹9,502.18 Cr ₹8,810.59 Cr ₹7,742.45 Cr ₹6,528.18 Cr ₹6,482.11 Cr ₹5,281.76 Cr ₹5,775.84 Cr
Profit Before Exceptional Items & Tax ₹367.53 Cr ₹241.78 Cr ₹202.05 Cr ₹140.27 Cr ₹140.75 Cr ₹120.32 Cr ₹187.51 Cr
Exceptional Items -₹83 Lakh ₹0 ₹0 -₹17.57 Cr ₹200.63 Cr ₹0 ₹0
Profit Before Tax ₹366.7 Cr ₹241.78 Cr ₹202.05 Cr ₹122.7 Cr ₹341.38 Cr ₹120.32 Cr ₹187.51 Cr
Total Tax Expense ₹84.37 Cr ₹61.4 Cr ₹50.32 Cr ₹23.96 Cr ₹66.26 Cr ₹58.43 Cr ₹59.25 Cr
Net Profit ₹282.33 Cr ₹180.38 Cr ₹151.73 Cr ₹98.74 Cr ₹285.39 Cr ₹84.3 Cr ₹128.26 Cr
Other Comprehensive Income -₹1.7 Cr -₹87 Lakh ₹19 Lakh ₹34 Lakh -₹7 Lakh ₹2.95 Cr -₹11.37 Lakh
Total Comprehensive Income ₹280.63 Cr ₹179.51 Cr ₹151.92 Cr ₹99.08 Cr ₹285.32 Cr ₹87.25 Cr ₹128.15 Cr
EBITDA (computed) ₹690.09 Cr ₹521.34 Cr ₹423.48 Cr ₹325.11 Cr ₹278.9 Cr ₹269.58 Cr ₹402.91 Cr
Basic EPS ₹44.31 ₹58.26 ₹49.01 ₹31.89 ₹88.86 ₹19.99 ₹41.43
Diluted EPS ₹44.31 ₹58.26 ₹49.01 ₹31.89 ₹88.86 ₹19.99 ₹41.43
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹6,126.12 Cr ₹5,790.4 Cr ₹5,281.12 Cr ₹4,543.48 Cr
Non-current Assets ₹4,636.39 Cr ₹3,978.61 Cr ₹3,336.98 Cr ₹2,895.18 Cr
Current Assets ₹1,489.73 Cr ₹1,811.79 Cr ₹1,944.14 Cr ₹1,648.3 Cr
Property, Plant & Equipment ₹4,551.29 Cr ₹3,825.95 Cr ₹3,196.76 Cr ₹2,707.36 Cr
Inventories ₹887.99 Cr ₹1,168.8 Cr ₹1,103.7 Cr ₹753.05 Cr
Trade Receivables ₹352.66 Cr ₹366.04 Cr ₹389.45 Cr ₹436.26 Cr
Cash & Equivalents ₹31.06 Cr ₹6.51 Cr ₹26.75 Cr ₹1.81 Cr
Equity (Net Worth) ₹2,537.44 Cr ₹1,871.04 Cr ₹1,716.3 Cr ₹1,587.61 Cr
Equity Share Capital ₹33.51 Cr ₹30.96 Cr ₹30.96 Cr ₹30.96 Cr
Borrowings (Non-current) ₹919.13 Cr ₹1,040.09 Cr ₹725.08 Cr ₹550.77 Cr
Borrowings (Current) ₹659.34 Cr ₹764.18 Cr ₹596.03 Cr ₹543.3 Cr
Total Debt (computed) ₹1,578.47 Cr ₹1,804.27 Cr ₹1,321.11 Cr ₹1,094.07 Cr
Current Liabilities ₹2,012.62 Cr ₹2,320.18 Cr ₹2,373.77 Cr ₹1,863.89 Cr
Total Liabilities ₹3,588.68 Cr ₹3,919.36 Cr ₹3,564.82 Cr ₹2,955.87 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹768.99 Cr ₹361.99 Cr ₹438.46 Cr ₹325.91 Cr ₹89.75 Cr
Investing Cash Flow -₹766.98 Cr -₹735.99 Cr -₹503.45 Cr -₹330.32 Cr ₹93.48 Cr
Financing Cash Flow ₹22.54 Cr ₹353.76 Cr ₹89.93 Cr -₹42 Lakh -₹179.59 Cr
Capital Expenditure -₹6.86 Cr -₹7.71 Cr -₹10.92 Cr -₹4.11 Cr ₹379.92 Cr
Free Cash Flow (computed) ₹762.13 Cr ₹354.28 Cr ₹427.54 Cr ₹321.8 Cr -₹290.17 Cr
Dividends Paid ₹75.31 Cr ₹24.59 Cr ₹22.97 Cr ₹23.04 Cr ₹18.39 Cr
Net Change in Cash ₹24.55 Cr -₹20.24 Cr ₹24.94 Cr -₹4.83 Cr ₹3.64 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹2,361.4 Cr ₹2,551.06 Cr ₹2,410.71 Cr ₹2,503.03 Cr ₹2,188 Cr ₹2,423.76 Cr ₹2,143.63 Cr ₹2,282.43 Cr ₹2,036.57 Cr ₹2,119.19 Cr ₹1,870.64 Cr ₹1,892.37 Cr
Other Income ₹39.2 Cr ₹74 Lakh ₹2.17 Cr ₹1.4 Cr ₹1.59 Cr ₹5.82 Cr ₹4.34 Cr ₹2.8 Cr ₹4.65 Cr ₹4.55 Cr ₹10.73 Cr ₹5.8 Cr
Total Income ₹2,400.6 Cr ₹2,551.8 Cr ₹2,412.88 Cr ₹2,504.43 Cr ₹2,189.59 Cr ₹2,429.58 Cr ₹2,147.97 Cr ₹2,285.23 Cr ₹2,041.22 Cr ₹2,123.74 Cr ₹1,881.37 Cr ₹1,898.17 Cr
Cost of Materials Consumed ₹484.66 Cr ₹597.82 Cr ₹660.85 Cr ₹669.1 Cr ₹488.26 Cr ₹642.29 Cr ₹584.28 Cr ₹630.98 Cr ₹501.46 Cr ₹515.96 Cr ₹407.33 Cr ₹394.17 Cr
Purchases of Stock-in-Trade ₹40.25 Cr ₹40.81 Cr ₹63.21 Cr ₹44.19 Cr ₹30.59 Cr ₹25.34 Cr ₹34.48 Cr ₹21.39 Cr ₹113.35 Cr ₹114.11 Cr ₹91 Cr ₹1.22 Cr
Changes in Inventories ₹83.51 Cr ₹53.07 Cr -₹39.69 Cr -₹35.97 Cr ₹14.44 Cr -₹45.66 Cr ₹6 Cr -₹25.24 Cr ₹18.61 Cr -₹12.56 Cr ₹22 Lakh ₹1.39 Cr
Employee Benefit Expense ₹33.68 Cr ₹34.77 Cr ₹31.64 Cr ₹30.6 Cr ₹30.1 Cr ₹30.76 Cr ₹29.82 Cr ₹30.21 Cr ₹29.5 Cr ₹27.01 Cr ₹22.74 Cr ₹22.37 Cr
Finance Costs ₹26.41 Cr ₹46.81 Cr ₹49.28 Cr ₹44.68 Cr ₹44.53 Cr ₹44.07 Cr ₹39.91 Cr ₹35.86 Cr ₹32.63 Cr ₹31.41 Cr ₹29.05 Cr ₹27.58 Cr
Depreciation & Amortisation ₹41.23 Cr ₹41.22 Cr ₹38.48 Cr ₹34.45 Cr ₹32.59 Cr ₹27.46 Cr ₹27.58 Cr ₹27.56 Cr ₹26.03 Cr ₹26.25 Cr ₹27.95 Cr ₹20.53 Cr
Other Expenses ₹1,555.08 Cr ₹1,648.17 Cr ₹1,536.62 Cr ₹1,647.25 Cr ₹1,480.96 Cr ₹1,646.87 Cr ₹1,372.7 Cr ₹1,502.46 Cr ₹1,268.51 Cr ₹1,371.51 Cr ₹1,255.32 Cr ₹1,377.8 Cr
Total Expenses ₹2,264.82 Cr ₹2,462.67 Cr ₹2,340.39 Cr ₹2,434.3 Cr ₹2,121.47 Cr ₹2,371.13 Cr ₹2,094.77 Cr ₹2,223.22 Cr ₹1,990.09 Cr ₹2,073.69 Cr ₹1,833.61 Cr ₹1,845.06 Cr
Profit Before Exceptional Items & Tax ₹135.78 Cr ₹89.13 Cr ₹72.49 Cr ₹70.13 Cr ₹68.12 Cr ₹58.45 Cr ₹53.2 Cr ₹62.01 Cr ₹51.13 Cr ₹50.05 Cr ₹47.76 Cr ₹53.11 Cr
Exceptional Items ₹0 -₹83 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹135.78 Cr ₹88.3 Cr ₹72.49 Cr ₹70.13 Cr ₹68.12 Cr ₹58.45 Cr ₹53.2 Cr ₹62.01 Cr ₹51.13 Cr ₹50.05 Cr ₹47.76 Cr ₹53.11 Cr
Total Tax Expense ₹25.5 Cr ₹23.04 Cr ₹18.55 Cr ₹17.28 Cr ₹17.77 Cr ₹14.61 Cr ₹13.75 Cr ₹15.27 Cr ₹13.39 Cr ₹12.26 Cr ₹12.09 Cr ₹12.58 Cr
Net Profit ₹110.28 Cr ₹65.26 Cr ₹53.94 Cr ₹52.85 Cr ₹50.35 Cr ₹43.84 Cr ₹39.45 Cr ₹46.74 Cr ₹37.74 Cr ₹37.79 Cr ₹35.67 Cr ₹40.53 Cr
Other Comprehensive Income -₹1.14 Cr -₹19 Lakh -₹18 Lakh -₹19 Lakh -₹98 Lakh ₹4 Lakh ₹3 Lakh ₹4 Lakh ₹8 Lakh ₹4 Lakh ₹4 Lakh ₹3 Lakh
Total Comprehensive Income ₹109.14 Cr ₹65.07 Cr ₹53.76 Cr ₹52.66 Cr ₹49.37 Cr ₹43.88 Cr ₹39.48 Cr ₹46.78 Cr ₹37.82 Cr ₹37.83 Cr ₹35.71 Cr ₹40.56 Cr
EBITDA (computed) ₹203.42 Cr ₹177.16 Cr ₹160.25 Cr ₹149.26 Cr ₹145.24 Cr ₹129.98 Cr ₹120.69 Cr ₹125.43 Cr ₹109.79 Cr ₹107.71 Cr ₹104.76 Cr ₹101.22 Cr
Basic EPS ₹17.31 ₹10.42 ₹8.71 ₹17.07 ₹16.26 ₹14.16 ₹12.74 ₹15.10 ₹12.19 ₹12.21 ₹11.52 ₹13.09
Diluted EPS ₹17.31 ₹10.42 ₹8.71 ₹17.07 ₹16.26 ₹14.16 ₹12.74 ₹15.10 ₹12.19 ₹12.21 ₹11.52 ₹13.09
Latest 12 quarters shown of 25 on record.
Segment · Q4 FY26 (latest quarter) Revenue Result (PBIT) Assets Liabilities
Bio-based Specialities and Performance Chemicals ₹302.55 Cr ₹34.47 Cr ₹3,595.99 Cr ₹737.05 Cr
Potable Spirits ₹1,690.09 Cr ₹67.78 Cr ₹596.6 Cr ₹326.53 Cr
Ennature Biopharma ₹63.49 Cr ₹3.01 Cr ₹426.42 Cr ₹92.49 Cr
Bio-Fuel ₹305.27 Cr ₹30.21 Cr ₹1,429.96 Cr ₹92.27 Cr
Segment · FY 2026 (annual) Revenue Result (PBIT) Assets Liabilities
Bio-based Specialities and Performance Chemicals ₹1,202.07 Cr ₹138.27 Cr - -
Potable Spirits ₹6,946.43 Cr ₹284.93 Cr - -
Ennature Biopharma ₹207.77 Cr ₹7.23 Cr - -
Bio-Fuel ₹1,469.93 Cr ₹115.23 Cr - -
Want more history and ratios?
You're viewing the latest exchange-filed financials for India Glycols Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of India Glycols Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 59.63%, foreign institutional investors hold 2.27%, domestic institutional investors hold 5.20%, retail and other public shareholders hold 32.90% of India Glycols Limited. The company had 52,848 shareholders on record.

Promoters: 59.63%DII (Domestic Institutional): 5.20%FII (Foreign Institutional): 2.27%Retail & Others: 32.90%
Mar 2026
QUARTER
59.63% Promoters
5.20% DII (Domestic Institutional)
2.27% FII (Foreign Institutional)
32.90% Retail & Others
Promoter holding - history
Now 59.63% · Mar 2026High 61.07% · Dec 2015Low 59.63% · Nov 2025
58%59.3%60.5%61.8%63%Dec 2015Jun 2018Dec 2020Jun 2023Nov 2025Dec 2015: 61.07%Mar 2016: 61.07%Jun 2016: 61.07%Sep 2016: 61.07%Dec 2016: 61.07%Mar 2017: 61.07%Jun 2017: 61.07%Sep 2017: 61.07%Dec 2017: 61.01%Mar 2018: 61.01%Jun 2018: 61.01%Sep 2018: 61.01%Dec 2018: 61.01%Mar 2019: 61.01%Jun 2019: 61.01%Sep 2019: 61.01%Dec 2019: 61.02%Mar 2020: 61.02%Jun 2020: 61.02%Sep 2020: 61.02%Dec 2020: 61.02%Mar 2021: 61.02%Jun 2021: 61.02%Sep 2021: 61.02%Dec 2021: 61.02%Mar 2022: 61.02%Jun 2022: 61.02%Sep 2022: 61.01%Dec 2022: 61.01%Mar 2023: 61.01%Jun 2023: 61.01%Sep 2023: 61.01%Dec 2023: 61.01%Mar 2024: 61.01%Jun 2024: 61.01%Sep 2024: 61.01%Dec 2024: 61.01%Mar 2025: 61.01%Jun 2025: 61.01%Sep 2025: 61.01%Nov 2025: 59.63%Dec 2025: 59.63%Mar 2026: 59.63%61.07%59.63%59.63%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Nov 2025Sep 2025Jun 2025Mar 2025
Promoters59.63%59.63%59.63%61.01%61.01%61.01%
Public40.37%40.37%40.37%38.99%38.99%38.99%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters59.63%61.01%61.01%61.01%61.02%61.02%61.02%61.01%61.01%61.07%61.07%
Public40.37%38.99%38.99%38.99%39.00%38.98%38.99%38.99%38.99%38.93%38.93%
Promoter change (YoY, %pts)-1.38+0.00+0.00-0.01+0.00+0.00+0.01+0.00-0.06+0.00-

Board & Governance of India Glycols Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of India Glycols Limited has 8 directors - 4 independent and 3 executive. The board is chaired by UMA SHANKAR BHARTIA.

DirectorPositionOn board sinceListed boards
UMA SHANKAR BHARTIA Executive Director · MD · Chairperson 1996-11-29 2
JAYSHREE BHARTIA Non-Executive - Non Independent Director 1999-05-28 1
SHUKLA WASSAN Non-Executive - Independent Director 2020-04-01 3
PRAGYA BHARTIA BARWALE Executive Director 2020-06-24 2
ALOK SINGHAL Executive Director 2023-12-01 1
RAVI KUMAR Non-Executive - Independent Director 2024-02-02 3
SAMRAT BANERJEE Non-Executive - Independent Director 2024-10-01 1
SUSHIL DUTT SALWAN Non-Executive - Independent Director 2024-10-01 1
Board Committees
CommitteeMembers
Audit Committee RAVI KUMAR (Chairperson), SAMRAT BANERJEE, ALOK SINGHAL
Nomination and remuneration committee RAVI KUMAR (Chairperson), SHUKLA WASSAN, SUSHIL DUTT SALWAN
Stakeholders Relationship Committee SHUKLA WASSAN (Chairperson), SAMRAT BANERJEE, UMA SHANKAR BHARTIA
Risk Management Committee UMA SHANKAR BHARTIA (Chairperson), PRAGYA BHARTIA BARWALE, RAVI KUMAR, SHUKLA WASSAN, ALOK SINGHAL, RUPARK SARSWAT, ANAND SINGHAL, ATUL GOVIL
Corporate Social Responsibility Committee UMA SHANKAR BHARTIA (Chairperson), PRAGYA BHARTIA BARWALE, SAMRAT BANERJEE, ALOK SINGHAL

Group Structure of India Glycols Limited

India Glycols Limited has 3 subsidiary companies, 1 joint venture, and 1 associated company. This group structure data is as of FY 2023. The corporate group structure reflects India Glycols Limited's business expansion strategy and organizational complexity.

3
Subsidiary companies
1
Joint ventures
1
Associated companies
Key Subsidiaries
Company Name CIN Shares Held
Igl Chemicals And Services Private Limited U24200UR2021PTC012141 -
Ennature Bio Pharma Private Limited U24290UR2021PTC013005 -
Igl Finance Limited U65922UR1997PLC022992 -

Showing major subsidiaries. Total: 3.

Charges & Borrowings of India Glycols Limited

Open charges
₹3,185.68 Cr
Satisfied charges
₹12,932 Cr
Breakdown by lending institutions
Sbicap Trustee Company Limited₹2,398.41 Cr
Others₹784.80 Cr
Axis Bank Limited₹2.26 Cr
Hdfc Bank Limited₹0.20 Cr
Latest charge details
DateLenderAmountStatus
13 May 2026 Others ₹25 Cr Open
11 Mar 2026 Others ₹16 Lakh Open
11 Mar 2026 Others ₹18 Lakh Open
06 Feb 2026 Others ₹28 Lakh Open
22 Jan 2026 Others ₹157 Cr Open

Total charge records: 214 View all charges

Employees and EPFO Compliance at India Glycols Limited

India Glycols Limited has a workforce of 1,347 employees as of Mar 26, 2024.

Employee count
1,347
Active EPFO establishments
5
Employee growth
4.18%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of India Glycols Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of India Glycols Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of India Glycols Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for India Glycols Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of India Glycols Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by India Glycols Limited

MSME Payment Delays by India Glycols Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of India Glycols Limited

Subsidiaries & Group Companies of India Glycols Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of India Glycols Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of India Glycols Limited

MCA Filings & Documents of India Glycols Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on India Glycols Limited

Charges
19 May 2026
A charge registered on 24 Jun 2022 via Charge ID 100585966 with Sbicap Trustee Company Limited was fully satisfied on 19 May 2026.
Charges
15 May 2026
A charge with Sbicap Trustee Company Limited of Rs. 100.00 Cr registered on 18 May 2022 with Charge ID 100580961 was modified on 15 May 2026.
Charges
13 May 2026
A charge with Others amounted to Rs. 25.00 Cr with Charge ID 101302973 was registered on 13 May 2026.
Charges
13 May 2026
A charge registered on 27 Dec 2023 via Charge ID 100850683 with Tata Cleantech Capital Limited was fully satisfied on 13 May 2026.
Charges
10 Apr 2026
A charge registered on 28 Aug 2024 via Charge ID 100971898 with Others was fully satisfied on 10 Apr 2026.
Charges
04 Apr 2026
A charge registered on 23 Jul 2025 via Charge ID 101134940 with Others was fully satisfied on 04 Apr 2026.

Frequently Asked Questions about India Glycols Limited

India Glycols Limited is an active public limited company in the chemicals and materials sector based in Udham Singh Nagar, Uttarakhand, India. It was incorporated on 19 November 1983 (43+ years old) and is registered under CIN L24111UR1983PLC009097. Listed on BSE: 500201 and NSE: INDIAGLYCO. The company has 1,347 employees.

India Glycols Limited reported revenue of ₹9,053.5 Cr for FY 2025 (up 14.00% YoY).

The current directors of India Glycols Limited are:

The primary industry of India Glycols Limited is chemicals and materials. The company specifically operates in specialty chemicals. The company is currently active in this sector.

Yes. India Glycols Limited is listed on both BSE (code: 500201) and NSE (symbol: INDIAGLYCO).

India Glycols Limited can be reached at the registered office: A – 1 Industrial Area Bazpur Road Kashipur, Udham Singh Nagar, Uttarakhand, India – 244713, or through the website indiaglycols.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available